COVID-19 UPDATE: Click here for current news.
The Rx Consultant

Non Subscriber: Add to Cart

More Than Stressed Out: Addressing Anxiety and Panic

Clicking the "View this Article" button will open the issue as a resizable PDF. To take the test for the issue, return to this Introduction page and click the "Take the Test" button. The Introduction page will remain open after you open this issue.
You may need to re-size or close the issue in order to see the Introduction page.

Overview

Before the COVID-19 pandemic, 29% of the US population experienced at least one Diagnostic and Statistical Manual (DSM-5) anxiety disorder during their lifetimes, with a one-year adult prevalence of 7% for social anxiety disorder (SAD), 2 to 3% for panic disorder (PD), and 3% for generalized anxiety disorder (GAD).Anxiety disorders are about twice as common in women as they are in men.

Since the start of the COVID-19 pandemic, it is no surprise that Centers for Disease Control and Prevention (CDC) data show that the US population is experiencing significantly more anxiety. In fact, during the period from the last 2 weeks in August 2020 through mid-December 2020, significant increases were seen in the percentage of adults who reported experiencing symptoms of an anxiety disorder (from 31.4% to 36.9%). During the same time frame, adults who reported taking prescription medication or receiving counseling for a mental health disorder of any kind increased from 22.4% to 25.0%. The percentage of people with unmet mental health treatment needs was significantly higher during the pandemic and rose from 9.2% in August 2020 to 12.4% in December of 2020.

Details

Publication Date: 08/23/2021
Expiration Date: 08/23/2024
CE Credit: 1.5 (0.15 CEU)
Type of Activity: Knowledge-based

This program was developed by The Rx Consultant and published by Continuing Education Network, Inc. The Rx Consultant accepts no advertising or financial support from the pharmaceutical industry and is funded solely by the purchase of programs. The Rx Consultant is dedicated to providing unbiased, balanced information to health care practitioners.

Programs developed by The Rx Consultant are written by health care providers with expertise in the topic area, peer-reviewed, extensively edited, and fact-checked. This development process was created to insure that every program presents information that is current, accurate, relevant to "real world" health care providers, and written in an easy reading, "plain English" style.

Authors

Julie A. Dopheide, PharmD,BCPP, FASHP is Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California School of Pharmacy and Keck School of Medicine. She is a credentialled provider at LAC and USC’s psychiatry clinic. She also provides care for inpatients with psychiatric and medical conditions.

Disclosure Statement

Dr. Dopheide reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.

Target Audience

This accredited program is targeted to pharmacists .

Goals & Objectives

At the conclusion of this program, participants will be able to:

    1. Identify the criteria for diagnosing social anxiety disorder, generalized anxiety disorder, and panic disorder. Differentiate these disorders from situational anxiety.
    2. Recognize the role of nonpharmacologic interventions such as cognitive-behavioral therapy, mindfulness, and lifestyle in the treatment of social anxiety disorder, generalized anxiety disorder, and panic disorder.
    3. Compare the advantages and disadvantages of serotonergic antidepressants, pregabalin, gabapentin, buspirone, and hydroxyzine in the treatment of social anxiety disorder, generalized anxiety disorder, and panic disorder.
    4. In the treatment of panic and anxiety disorders, identify appropriate roles for benzodiazepines.

Accreditation Statements

The Rx Consultant is a publication of Continuing Education Network, Inc.

ACPE logo
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education as a provider of continuing pharmacy education.

California Board of Registered Nursing logo
Continuing Education Network is approved by the California Board of Registered Nursing, Provider Number CEP 13118. Programs approved by CA BRN are accepted by most State Boards of Nursing.

ACPE Universal Activity Number: 0428-0000-21-010-H01-P


Exam & Credit Statement Procedures

Upon successful completion of this program and the post test (70%), 1.5 hours of continuing education credit will be awarded. To receive credit and your exam score, please complete the exam questions and program evaluation.

Editorial and Review Board

Chief Editor and CE Administrator


Terry M. Baker, PharmD

Managing Editor


Tracy Farnen, PharmD

Associate Editors


James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Coordinator
Kaiser Permanente
Oakland, CA

Associate Clinical Professor
School of Pharmacy
University of California San Francisco
San Francisco, CA

Richard Ron Finley, B.S. Pharm.,R.Ph.
Clinical Pharmacist (volunteer faculty)
University of California, San Francisco (UCSF) Memory and Aging Center
Lecturer (Emeritus) UCSF, Department of Clinical Pharmacy
Health Sciences Clinical Professor, UCSF School of Pharmacy
San Francisco, CA

Consultant Pharmacist
Ray Dolby Brain Health Center, Sutter Health/CPMC
San Francisco, CA

Consult Pharmacist Aging and Adult Health Services
San Francisco Health Department
San Francisco, CA

Julio R. Lopez, PharmD, FCSHP
Chief of Pharmacy Service
VA Northern California Health Care System

Adjunct Clinical Professor
College of Pharmacy
Touro University
Vallejo, CA

Assistant Clinical Professor
School of Pharmacy
University of California, San Francisco
San Francisco, CA Adjunct Professor
Thomas J. Long School of Pharmacy
University of the Pacific
Stockton, CA

Visiting Associate Professor and Lecturer
Nursing School
Samuel Merritt University
Oakland, CA

Pamela Mausner, MD

Helen Berlie, Pharm.D. CDE, BCACP
Clinical Assistant Professor, Pharmacy Practice
Wayne State University
Detroit, MI

Ambulatory Care Specialist - Diabetes
Health Centers Detroit Medical Group
Detroit, MI

Senior Editorial Advisor


Gerard Hatheway, PharmD, PhD

Editorial Advisors


Belinda M. Danielson, RPh
Christopher M. DeSoto, PharmD
Angie S. Graham, PharmD
Cynthia Chan Huang, PharmD, MBA
Fred Plageman, PharmD

Editorial Advisor and Clinical Practice Consultant for Nurse Practitioners


Emily K.
Meuleman, RN, C, MS

About the Rx Consultant

The Rx Consultant is a monthly publication dedicated to providing health care professionals with the information they need to educate patients about drugs and manage drug therapy. The reader is responsible for confirming the information presented here and interpreting it in relation to each patient's specific situation before utilizing the information.

Technical Specifications

Hardware requirements

Any hardware that supports Microsoft Windows, Apple Mac OS, iOS, or Android, and meets the software requirements.

Software requirements

Browser that supports TLS 1.1 + and PDF files.

This includes Microsoft Internet Explorer 11, Google Chrome 38, Google Android OS 5.0 Browser, Apple Safari (version 7 for desktop, 5 for mobile), Mozilla Firefox 27, newer versions of these browsers, as well as some earlier versions that may require additional configuration.

Adobe Acrobat Reader is recommended, and is required for some browsers.

Note: TLS 1.1 and 1.2 support is required for browser security. Click here for TLS browser support details.

Internet Connectivity

Required. Broadband recommended. (T1, DSL, Cable, G4 or higher.)

Contact Us

Exam Processing Inquiries

The Rx Consultant
rxmail@rxconsultant.com
1-800-798-3353

Educational Content Inquiries

The Rx Consultant
editor@rxconsultant.com
1-800-798-3353

Non Subscriber: Add to Cart